People with depression increasingly using cannabis

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Claim CPD for this activity

Educational Activities (EA)
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)
0 minutes

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)
0 minutes

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Dr Linda Calabresi

According to new research recently published in JAMA Network Open, more people with depression are self-medicating with cannabis, which evidence suggests is unlikely to be beneficial to say the least.

US researchers have just published their analysis of data from the ongoing National Health and Nutrition Examination Survey (NHANES), comparing the prevalence of depression and cannabis use in 2005/6 with 2015/16 among 16,000 American adults (aged 20 to 59) taken from a cross-section of the population.

Over the decade in question, it appears the percentage of adults who reported having used cannabis in the previous month increased by almost 50% (from 12.2% to 17.3%).

And although the prevalence of depression did not change over this time period, the study found that, with time, people with depression were increasingly likely to not only report having used cannabis in the last month, they were more than 200% more likely to be using cannabis on a daily or almost daily basis.

So while the prevalence of cannabis use in the general population was found to be 17.3% in 2016, among people with depression it was approximately 30%. And if you consider daily or almost daily use, the study shows this was the pattern of use for just over 6% of the general cohort at the end of the study compared with 15% if you just look at people with depression.

Of course this is a US study, so the increasing prevalence of cannabis use over the past two decades has to be viewed in the context of increased availability and more permissive laws across the majority of American states. And you have to take into account US advertising. Cannabis is frequently marketed as a remedy for mood disorders and there has been a widespread decrease in the public’s perception of risks associated with cannabis use despite existing evidence that cannabis can worsen depressive symptoms.

And that’s where the real concern lies. People with depression might be using cannabis in the mistaken belief it could be beneficial whereas the exact opposite is more likely.

“Individuals with depression who use cannabis may represent a high-risk group for cannabis-involved adverse consequences, potential worsening of symptoms, and suicidality,” the study authors said.

Interestingly the study findings do not suggest that cannabis use causes depression. Despite the quite significant jump in the percentage of people using the drug the prevalence of depression remained the same.

Nonetheless, the higher proportion of depressed people using cannabis represents an opportunity for intervention that might improve psychological outcomes, the researchers suggest.

“In health care settings where depression is addressed, discussion with patients regarding the frequency of their cannabis use, strategies for cutting back and the effects of cannabis on depressive symptoms may be useful,” they concluded.

Ref: JAMA Network Open.2020;3(8):e2013802. doi:10.1001/jamanetworkopen.2020.13802

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Alberto Pinzon Charry

A/Prof Alberto Pinzon Charry

Urticaria Management in Primary Care

A/Prof Ron Dick

A/Prof Ron Dick

LDL Management Demystified

A/Prof Samantha Hocking

A/Prof Samantha Hocking

Tirzepatide for Chronic Weight Management

Dr Rupert Hinds

Dr Rupert Hinds

Diarrhoea in Kids – When to Worry

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

We asked GPs views on the Government's proposal to withhold MBS payments from pathology companies when they don't upload results to My Health Record

I support the proposal

0%

I support the proposal, but the Government should improve the useability of My Health Record first

0%

I do not support the proposal

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.